| 2024-06-21 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 37,000 0.028% | $39.24 | $1.45M | +3.52% | |
| 2024-03-19 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 18,681 0.0156% | $57.18 | $1.07M | -22.86% | |
| 2023-12-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 24,000 0.0204% | $61.13 | $1.47M | -6.26% | |
| 2023-11-17 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 8,894 0.0077% | $49.99 | $444,620 | +15.92% | |
| 2023-10-17 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 24,000 0.0213% | $49.00 | $1.18M | +17.09% | |
| 2023-04-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 500 0.0004% | $74.05 | $37,025 | -20.87% | |
| 2023-03-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 500 0.0004% | $65.33 | $32,665 | -1.34% | |
| 2023-02-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 500 0.0004% | $52.61 | $26,305 | +11.65% | |
| 2023-01-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 500 0.0004% | $50.70 | $25,350 | +8.59% | |
| 2022-12-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 500 0.0005% | $49.93 | $24,965 | +4.55% | |
| 2022-11-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 500 0.0005% | $60.83 | $30,415 | -14.19% | |
| 2022-09-08 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 15,000 0.013% | $65.00 | $975,000 | -13.83% | |
| 2022-08-11 | Sale | Apellis Pharmaceuticals, Inc. APLS | 60,000 0.0551% | $65.63 | $3.94M | -6.65% | ||
| 2022-06-27 | Sale | Apellis Pharmaceuticals, Inc. APLS | 2,682 0.0025% | $46.79 | $125,486 | +30.39% | ||
| 2022-06-23 | Sale | Apellis Pharmaceuticals, Inc. APLS | 30,000 0.0269% | $45.00 | $1.35M | +27.28% | ||
| 2021-05-20 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 11,546 0.0141% | $48.10 | $555,363 | -5.56% | |
| 2021-05-19 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 15,224 0.0196% | $50.00 | $761,200 | -3.98% | |
| 2021-05-18 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 298,976 0.3818% | $52.85 | $15.8M | -9.74% | |
| 2020-12-14 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 50,000 0.0699% | $54.67 | $2.73M | -10.38% | |
| 2020-12-07 | Sale | Apellis Pharmaceuticals, Inc. APLS | director | 37,128 0.0488% | $50.71 | $1.88M | -8.06% |